Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

EMR vs AME vs HON vs DHR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EMR
Emerson Electric Co.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$79.14B
5Y Perf.+131.5%
AME
AMETEK, Inc.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$53.23B
5Y Perf.+153.4%
HON
Honeywell International Inc.

Conglomerates

IndustrialsNASDAQ • US
Market Cap$135.04B
5Y Perf.+46.1%
DHR
Danaher Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$121.14B
5Y Perf.+15.9%

EMR vs AME vs HON vs DHR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EMR logoEMR
AME logoAME
HON logoHON
DHR logoDHR
IndustryIndustrial - MachineryIndustrial - MachineryConglomeratesMedical - Diagnostics & Research
Market Cap$79.14B$53.23B$135.04B$121.14B
Revenue (TTM)$18.32B$7.60B$36.76B$24.78B
Net Income (TTM)$2.44B$1.53B$4.10B$3.69B
Gross Margin52.7%36.6%36.9%60.7%
Operating Margin19.8%26.2%14.9%21.0%
Forward P/E21.7x28.6x20.2x20.3x
Total Debt$13.76B$2.28B$34.58B$18.42B
Cash & Equiv.$1.54B$458M$12.49B$4.62B

EMR vs AME vs HON vs DHRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EMR
AME
HON
DHR
StockMay 20May 26Return
Emerson Electric Co. (EMR)100231.5+131.5%
AMETEK, Inc. (AME)100253.4+153.4%
Honeywell Internati… (HON)100146.1+46.1%
Danaher Corporation (DHR)100115.9+15.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: EMR vs AME vs HON vs DHR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AME leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Honeywell International Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
EMR
Emerson Electric Co.
The Growth Play

EMR is the clearest fit if your priority is growth exposure.

  • Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
Best for: growth exposure
AME
AMETEK, Inc.
The Long-Run Compounder

AME carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.

  • 418.8% 10Y total return vs EMR's 207.0%
  • PEG 2.56 vs DHR's 33.47
  • PEG 2.56 vs 4.80
  • 20.1% margin vs HON's 11.2%
Best for: long-term compounding and valuation efficiency
HON
Honeywell International Inc.
The Income Pick

HON is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 15 yrs, beta 0.74, yield 2.2%
  • Beta 0.74, yield 2.2%, current ratio 1.32x
  • 7.8% revenue growth vs DHR's 2.9%
  • Beta 0.74 vs EMR's 1.57
Best for: income & stability and defensive
DHR
Danaher Corporation
The Defensive Pick

DHR is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.89, Low D/E 35.1%, current ratio 1.87x
Best for: sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthHON logoHON7.8% revenue growth vs DHR's 2.9%
ValueAME logoAMEPEG 2.56 vs 4.80
Quality / MarginsAME logoAME20.1% margin vs HON's 11.2%
Stability / SafetyHON logoHONBeta 0.74 vs EMR's 1.57
DividendsHON logoHON2.2% yield, 15-year raise streak, vs EMR's 1.5%
Momentum (1Y)AME logoAME+36.2% vs DHR's -11.4%
Efficiency (ROA)AME logoAME9.6% ROA vs DHR's 4.5%, ROIC 12.1% vs 5.9%

EMR vs AME vs HON vs DHR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EMREmerson Electric Co.
FY 2025
Intelligent Devices
68.5%$12.4B
Software and Control
31.5%$5.7B
AMEAMETEK, Inc.
FY 2025
Electronic Instruments Group
66.5%$4.9B
Electromechanical Group
33.5%$2.5B
HONHoneywell International Inc.
FY 2025
Aerospace
46.8%$17.5B
Safety And Productivity Solutions
25.1%$9.4B
Home And Building Technologies
19.7%$7.4B
Energy and Sustainability Solutions
8.4%$3.1B
DHRDanaher Corporation
FY 2025
Revenue from Contract with Customer, Measurement, Recurring
81.9%$20.1B
Revenue from Contract with Customer, Measurement, Nonrecurring
18.1%$4.4B

EMR vs AME vs HON vs DHR — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAMELAGGINGDHR

Income & Cash Flow (Last 12 Months)

AME leads this category, winning 4 of 6 comparable metrics.

HON is the larger business by revenue, generating $36.8B annually — 4.8x AME's $7.6B. AME is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to HON's 11.2%. On growth, AME holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.HON logoHONHoneywell Interna…DHR logoDHRDanaher Corporati…
RevenueTrailing 12 months$18.3B$7.6B$36.8B$24.8B
EBITDAEarnings before interest/tax$4.7B$2.3B$6.5B$7.2B
Net IncomeAfter-tax profit$2.4B$1.5B$4.1B$3.7B
Free Cash FlowCash after capex$3.1B$1.7B$4.2B$5.3B
Gross MarginGross profit ÷ Revenue+52.7%+36.6%+36.9%+60.7%
Operating MarginEBIT ÷ Revenue+19.8%+26.2%+14.9%+21.0%
Net MarginNet income ÷ Revenue+13.3%+20.1%+11.2%+14.9%
FCF MarginFCF ÷ Revenue+17.0%+22.4%+11.4%+21.4%
Rev. Growth (YoY)Latest quarter vs prior year+2.9%+11.3%-6.9%+3.7%
EPS Growth (YoY)Latest quarter vs prior year+28.2%+14.5%-41.9%+9.8%
AME leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — HON and DHR each lead in 3 of 7 comparable metrics.

At 29.0x trailing earnings, HON trades at a 20% valuation discount to AME's 36.3x P/E. Adjusting for growth (PEG ratio), AME offers better value at 3.25x vs DHR's 33.47x — a lower PEG means you pay less per unit of expected earnings growth.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.HON logoHONHoneywell Interna…DHR logoDHRDanaher Corporati…
Market CapShares × price$79.1B$53.2B$135.0B$121.1B
Enterprise ValueMkt cap + debt − cash$91.4B$55.1B$157.1B$134.9B
Trailing P/EPrice ÷ TTM EPS34.97x36.31x28.96x33.96x
Forward P/EPrice ÷ next-FY EPS est.21.70x28.56x20.24x20.29x
PEG RatioP/E ÷ EPS growth rate7.74x3.25x15.77x33.47x
EV / EBITDAEnterprise value multiple18.09x29.29x19.75x17.79x
Price / SalesMarket cap ÷ Revenue4.39x7.19x3.61x4.93x
Price / BookPrice ÷ Book value/share3.94x5.06x8.87x2.32x
Price / FCFMarket cap ÷ FCF29.67x31.85x25.04x23.03x
Evenly matched — HON and DHR each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

AME leads this category, winning 7 of 9 comparable metrics.

HON delivers a 23.1% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $7 for DHR. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs HON's 6/9, reflecting strong financial health.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.HON logoHONHoneywell Interna…DHR logoDHRDanaher Corporati…
ROE (TTM)Return on equity+12.1%+14.4%+23.1%+7.1%
ROA (TTM)Return on assets+5.8%+9.6%+5.3%+4.5%
ROICReturn on invested capital+8.2%+12.1%+12.6%+5.9%
ROCEReturn on capital employed+10.0%+15.0%+12.6%+7.0%
Piotroski ScoreFundamental quality 0–97767
Debt / EquityFinancial leverage0.68x0.21x2.24x0.35x
Net DebtTotal debt minus cash$12.2B$1.8B$22.1B$13.8B
Cash & Equiv.Liquid assets$1.5B$458M$12.5B$4.6B
Total DebtShort + long-term debt$13.8B$2.3B$34.6B$18.4B
Interest CoverageEBIT ÷ Interest expense6.46x23.34x3.92x18.13x
AME leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AME leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in AME five years ago would be worth $17,330 today (with dividends reinvested), compared to $7,681 for DHR. Over the past 12 months, AME leads with a +36.2% total return vs DHR's -11.4%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.8% vs DHR's -6.3% — a key indicator of consistent wealth creation.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.HON logoHONHoneywell Interna…DHR logoDHRDanaher Corporati…
YTD ReturnYear-to-date+4.4%+11.3%+9.4%-25.5%
1-Year ReturnPast 12 months+27.7%+36.2%+1.5%-11.4%
3-Year ReturnCumulative with dividends+76.2%+62.6%+14.7%-17.6%
5-Year ReturnCumulative with dividends+59.1%+73.3%+1.0%-23.2%
10-Year ReturnCumulative with dividends+207.0%+418.8%+132.4%+212.4%
CAGR (3Y)Annualised 3-year return+20.8%+17.6%+4.7%-6.3%
AME leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AME and HON each lead in 1 of 2 comparable metrics.

HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AME currently trades 95.6% from its 52-week high vs DHR's 70.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.HON logoHONHoneywell Interna…DHR logoDHRDanaher Corporati…
Beta (5Y)Sensitivity to S&P 5001.57x0.94x0.74x0.89x
52-Week HighHighest price in past year$165.15$243.18$248.18$242.80
52-Week LowLowest price in past year$109.53$170.47$186.76$170.74
% of 52W HighCurrent price vs 52-week peak+85.6%+95.6%+85.9%+70.5%
RSI (14)Momentum oscillator 0–10051.454.544.234.6
Avg Volume (50D)Average daily shares traded2.8M1.2M3.7M4.2M
Evenly matched — AME and HON each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.

Analyst consensus: EMR as "Buy", AME as "Buy", HON as "Buy", DHR as "Buy". Consensus price targets imply 44.3% upside for DHR (target: $247) vs 6.6% for AME (target: $248). For income investors, HON offers the higher dividend yield at 2.17% vs AME's 0.53%.

MetricEMR logoEMREmerson Electric …AME logoAMEAMETEK, Inc.HON logoHONHoneywell Interna…DHR logoDHRDanaher Corporati…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$161.31$247.73$243.83$247.00
# AnalystsCovering analysts41292842
Dividend YieldAnnual dividend ÷ price+1.5%+0.5%+2.2%+0.7%
Dividend StreakConsecutive years of raises3716151
Dividend / ShareAnnual DPS$2.10$1.23$4.63$1.23
Buyback YieldShare repurchases ÷ mkt cap+1.6%+0.8%+2.8%+2.5%
Evenly matched — EMR and HON each lead in 1 of 2 comparable metrics.
Key Takeaway

AME leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 3 categories are tied.

Best OverallAMETEK, Inc. (AME)Leads 3 of 6 categories
Loading custom metrics...

EMR vs AME vs HON vs DHR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is EMR or AME or HON or DHR a better buy right now?

For growth investors, Honeywell International Inc.

(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Honeywell International Inc. (HON) offers the better valuation at 29. 0x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EMR or AME or HON or DHR?

On trailing P/E, Honeywell International Inc.

(HON) is the cheapest at 29. 0x versus AMETEK, Inc. at 36. 3x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AMETEK, Inc. wins at 2. 56x versus Danaher Corporation's 33. 47x.

03

Which is the better long-term investment — EMR or AME or HON or DHR?

Over the past 5 years, AMETEK, Inc.

(AME) delivered a total return of +73. 3%, compared to -23. 2% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: AME returned +418. 8% versus HON's +132. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EMR or AME or HON or DHR?

By beta (market sensitivity over 5 years), Honeywell International Inc.

(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 57β — meaning EMR is approximately 111% more volatile than HON relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — EMR or AME or HON or DHR?

By revenue growth (latest reported year), Honeywell International Inc.

(HON) is pulling ahead at 7. 8% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EMR or AME or HON or DHR?

AMETEK, Inc.

(AME) is the more profitable company, earning 20. 0% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AME leads at 26. 2% versus 17. 5% for HON. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EMR or AME or HON or DHR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, AMETEK, Inc. (AME) is the more undervalued stock at a PEG of 2. 56x versus Danaher Corporation's 33. 47x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 2x forward P/E versus 28. 6x for AMETEK, Inc. — 8. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 44. 3% to $247. 00.

08

Which pays a better dividend — EMR or AME or HON or DHR?

All stocks in this comparison pay dividends.

Honeywell International Inc. (HON) offers the highest yield at 2. 2%, versus 0. 5% for AMETEK, Inc. (AME).

09

Is EMR or AME or HON or DHR better for a retirement portfolio?

For long-horizon retirement investors, AMETEK, Inc.

(AME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 0. 5% yield, +418. 8% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AME: +418. 8%, EMR: +207. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EMR and AME and HON and DHR?

These companies operate in different sectors (EMR (Industrials) and AME (Industrials) and HON (Industrials) and DHR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

EMR

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

AME

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Stocks Like

HON

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 6%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

DHR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EMR and AME and HON and DHR on the metrics below

Revenue Growth>
%
(EMR: 2.9% · AME: 11.3%)
Net Margin>
%
(EMR: 13.3% · AME: 20.1%)
P/E Ratio<
x
(EMR: 35.0x · AME: 36.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.